The controversy of using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in COVID-19 patients.
Amer HarkyCheryl Yan Ting ChorHenry NixonMilad JeilaniPublished in: Journal of the renin-angiotensin-aldosterone system : JRAAS (2021)